Cathy McMorris Rodgers - Chair of the House Energy and Commerce Committee | Official U.S. House headshot
Cathy McMorris Rodgers - Chair of the House Energy and Commerce Committee | Official U.S. House headshot
House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA) have announced a hearing titled “Examining Anti-Doping Measures in Advance of the 2024 Olympics.”
“Olympic athletes dedicate years of their lives to perfect their craft in order to represent the United States on the world stage. They—as well as athletes from every other country—deserve to compete on a level playing field that’s free of banned performance-enhancing drugs,” said Chairs Rodgers and Griffith. “The World Anti-Doping Agency, the governing body responsible for enforcing fair standards, has a questionable track record of fulfilling that mission. This hearing will give Members a chance to examine that track record, identify opportunities for improvement, and ensure that the best athletes are the ones taking home gold medals.”
The Subcommittee on Oversight and Investigations hearing is scheduled as follows:
WHAT: A Subcommittee on Oversight and Investigations hearing to examine anti-doping measures ahead of the 2024 Olympics.
DATE: Tuesday, June 25, 2024
TIME: 7:00 PM ET
LOCATION: 2123 Rayburn House Office Building
Confirmed witnesses include former Olympic athletes Michael Phelps and Allison Schmitt, along with Travis Tygart, Chief Executive Officer of the U.S. Anti-Doping Agency. Witold Banka, President of the World Anti-Doping Agency, has been invited.
This notice is at the direction of the Chair. The hearing will be open to the public and press and will be live-streamed online at https://energycommerce.house.gov/. For questions concerning the hearing, contact Lauren Kennedy with Committee staff at Lauren.Kennedy@mail.house.gov. Press-related inquiries should be directed to Christopher Krepich at Christopher.Krepich@mail.house.gov.
Main: (202) 225-3641
Press: (202) 226-4972